# Safety of Reduced Infliximab Infusion Time

> **NCT05340764** · PHASE4 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 96 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT05340764
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2023-05-04
- **Final completion:** 2023-05-04
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2024-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05340764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05340764, "Safety of Reduced Infliximab Infusion Time". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05340764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*